Blog

Comparing lobular vs. ductal Inflammatory Breast Cancer

Photo of Yoshiko Iwai from doximity.com

Aug 12, 2024, 12:58

Comparing lobular vs. ductal Inflammatory Breast Cancer

Society of Surgical Oncology shared on X:

“A new study in Annals of Surgical Oncology, comparing lobular vs. ductal IBC, shows that lobular IBC patients are more likely to be node-negative at presentation but node-positive at surgery, often with less comprehensive nodal exams.

Society of Surgical Oncology

‘Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer‘

Authors: Yoshiko Iwai, Stephany Perez-Rojas, Samantha M. Thomas, Audree B. Tadros, Steven G. Woodward, Jennifer Q. Zhang, Leisha C. Elmore, Gary M. Freedman, Julia C. Tchou, Aaron D. Bleznak, Oluwadamilola M. Fayanju.”

Comparing lobular vs. ductal Inflammatory Breast Cancer

Source: Society of Surgical Oncology/X

Aaron D. Bleznak Audree B. Tadros Breast Cancer cancer Gary M. Freedman Jennifer Q. Zhang Julia C. Tchou Leisha C. Elmore Oluwadamilola M. Fayanju OncoDaily Oncology Samantha M. Thomas Society of Surgical Oncology Stephany Perez-Rojas Steven G. Woodward Yoshiko Iwai

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity